1. Home
  2. LOAN vs YI Comparison

LOAN vs YI Comparison

Compare LOAN & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

N/A

Current Price

$4.29

Market Cap

51.9M

Sector

Real Estate

ML Signal

N/A

Logo 111 Inc.

YI

111 Inc.

N/A

Current Price

$7.07

Market Cap

49.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
LOAN
YI
Founded
1989
2010
Country
United States
China
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Retail-Drug Stores and Proprietary Stores
Sector
Real Estate
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
49.0M
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
LOAN
YI
Price
$4.29
$7.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.8K
19.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
10.33%
N/A
EPS Growth
2.08
N/A
EPS
0.35
N/A
Revenue
$9,688,641.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$12.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$2.48
52 Week High
$6.05
$11.35

Technical Indicators

Market Signals
Indicator
LOAN
YI
Relative Strength Index (RSI) 25.71 47.05
Support Level N/A $6.75
Resistance Level $4.59 $7.44
Average True Range (ATR) 0.07 0.22
MACD -0.01 -0.26
Stochastic Oscillator 0.00 8.46

Price Performance

Historical Comparison
LOAN
YI

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: